Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martijn C Briët

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Neurology and Neurosurgery|August 12, 2011
Hermann Hesse and L: two narratives of sciaticaMartijn C Briët, Joost Haan, Ad A Kaptein
Developmental Neurobiology|April 27, 2016
Hepatocyte nuclear factor-4 alpha in noise-induced cochlear neuropathyJane Bjerg Groth, Shyan-Yuan Kao, Martijn C Briët, et al.
Acta Cytologica|March 25, 2011
Effects of streamlining cervical cancer screening the Dutch way: consequences of changes in the Dutch KOPAC-based follow-up protocol and consensus-based limitation of equivocal cytologyMartijn C Briët, Thomas H D Berger, Marjolein van Ballegooijen, et al.
Molecular Oncology|April 21, 2015
Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growthSonam Dilwali, Martijn C Briët, Shyan-Yuan Kao, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Neurology and Neurosurgery|August 12, 2011
Hermann Hesse and L: two narratives of sciaticaMartijn C Briët, Joost Haan, Ad A Kaptein
Developmental Neurobiology|April 27, 2016
Hepatocyte nuclear factor-4 alpha in noise-induced cochlear neuropathyJane Bjerg Groth, Shyan-Yuan Kao, Martijn C Briët, et al.
Acta Cytologica|March 25, 2011
Effects of streamlining cervical cancer screening the Dutch way: consequences of changes in the Dutch KOPAC-based follow-up protocol and consensus-based limitation of equivocal cytologyMartijn C Briët, Thomas H D Berger, Marjolein van Ballegooijen, et al.
Molecular Oncology|April 21, 2015
Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growthSonam Dilwali, Martijn C Briët, Shyan-Yuan Kao, et al.
Pageof 1